You are here

Home » Content

Dev Kalp: Olgu Sunumu

Giant Heart: A Case Report

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2001

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Mitral valve disease is the most seen valvulopathy in rheumatic heart disease. Approximately 40 percent of all patients with rheumatic heart disease have combined mitral stenosis and mitral regurgitation. 35 years o ld woman suffering from dyspnea which had been begun one year ago and history of edema of extremites was admitted our cardiology department. In PA chest roentgenogram cardiothoracic ratio was 0.9. In echocardiographic evaluation of the heart left ventricular, left atrium, right ventricular and right atrium diameters are as follows; 13,8 cm, 12 cm, 5,5 cm, 10,4 cm. In doppler echocardiography confirmed with 40 mitral regurgitation, 40 tricuspit regurgitation, pulmonary artery pressure 50 mmHg, ejection fract ion 45 % have seen and no important symptomatology was seen before one year ago. We offer our patient becau se of having one of the biggest cardiomegaly that we find out and does not have any important complaint until a year ago.
Bookmark/Search this post with
Abstract (Original Language): 
Romatizmal kalp kapak hastalıklarında en fazla mitral kapak tutulumu olur. Olgul arın % 40'ında mitral darlık ve mitral yetmezlik beraber bulunur. Semptomlar kapak hastalığının derecesi ve sol ventrikül fonksiyonuyla uyumludur. Dispne, ortopne, yaygın ödem nedeniyle başvuran 35 yaşındaki bayan hastanın teleradyografisinde kardiyotorasik oran artmış (0.9), toraks orta-alt kısımlarında akciğer dokusu izlenmiyordu. Ekokardiyografisinde sol ventrikül diyastolik çapı 13,8 cm, sol atriyum çapı 12 cm, sağ ventrikül çapı 5,5 cm, sağ atriyum çapı 10,4 cm , 4 0 mitral yetmezlik, hafif mitral darlık, 40 triküspit yetmezlik saptandı. Sol ventrikü l ejeksiyon fraksiyonu % 45 ve pulmoner arter basıncı 50 mmHg olarak hesaplandı. Hasta semptomlarının son bir yı ldır mevcut olduğunu ifade ediyordu. Hastamızı bu zamana kadar saptadığımız en ileri kardiyomegalili olgu o lması ve bir yıl öncesine kadar önemli bir semptom tariflememesi nedeniyle sunmayı uygun bulduk.
FULL TEXT (PDF): 
PDF icon arastirmax-dev-kalp-olgu-sunumu.pdf
  • 3
153-155
  • Turkish

REFERENCES

References: 

1. Baller BE: Rheumatic and non rheumatic conditions producing valvular heart disease. Cardiovasc Clin 1986 ; 16 :3-6
2. Wood P. An appreciation of mitral stenosis: Part 1. Clinical features. Br Med J 1954; 1: 1051-1063 An appreciation of mitral stenosis: Part 2. Investigations end results. Br Med J 1954: 1: 1113-1124
3. Bowe JC, Bland EF, Spraque HB, White PB. The cause of mitral stenosis without surgery. 10 and 20 year prospective. Ann Intern Med. 1960; 52: 741 -749
4. Selzer A, Katayama F: Mitral regurgitation; Clinical patterns, pathology and natural
history. Medicine. 1972; 51: 337-366
5. Kligfield P, Hochreiter C, Viles N, Devereus R, Borer J. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetetive ventricular arrhytmias and, right and left ventricular ejection fraction. Am J
Cardiol 1987; 60: 397-399
6. Ling H, Enriquez-Sarano M, Seward J et al. Clinical outcome of mitral regurgitation due to failed leaflets. N Eng J Med 1996 ; 335: 1417-1423
7. Ramanathan K, Knowles J, Connar M et al. Natural history of chronic mitral insufficiency: Relation of peak systolik pressure/end systolic volume relation to morbidity and mortality. J Am Coll Cardiol 1984; 3: 1412-1416
8. Waller B, Howard J, Fess S: Pathology of mitral valve stenosis and pure mitral
regurgitation-part 1. Clin Cardiol 1994;17:330-336
9. Eisenberg MJ. Rheumatic heart disease in the developing world: prevalance, prevention and control. Eur Heart J 1993;14:122-128
10. Badui E, Delgado C, Enerso R et al. Silent giant left atrium. A case report.
Angiology 1995; 46: 445-448
11. Neubauer S, Kialze T, Schindler R et al. 31p magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease: altered cardiac high-energy
phosphate metabolism in heart failure. Circulation 1992; 86: 1810-1818
12. Conway MA, Bottomley PA, Ouwerkerk R Radda GK, Rajagopalon B. Mitral regurgitation impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation
1998; 97: 1716-1723
13. Sonel
A
. Elektrokardiyografi. Kardiyoloji, 3. baskı. Türk Tarih Kurumu Basımevi.
1987; 117-172

Thank you for copying data from http://www.arastirmax.com